Immunic
IMUX
IMUX
51 hedge funds and large institutions have $31.3M invested in Immunic in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
44% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 18
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $17K
Holders
51
Holding in Top 10
–
Calls
–
Puts
$17K
Top Buyers
| 1 | +$1.2M | |
| 2 | +$744K | |
| 3 | +$489K | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$396K |
| 5 |
ECM
Element Capital Management
New York
|
+$356K |
Top Sellers
| 1 | -$2.83M | |
| 2 | -$765K | |
| 3 | -$598K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$311K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$310K |